All Relations between (2R)-amino-5-phosphonovaleric acid (AP5) and striatum

Publication Sentence Publish Date Extraction Date Species
S Carboni, F Melis, L Pani, M Hadjiconstantinou, Z L Rossett. The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+). Neuroscience letters. vol 117. issue 1-2. 1991-04-01. PMID:1981252. the non-competitive nmda-receptor antagonist mk-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (mpp+). 1991-04-01 2023-08-11 rat
S Subramaniam, P McGonigl. Quantitative autoradiographic characterization of the binding of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine ([3H]MK-801) in rat brain: regional effects of polyamines. The Journal of pharmacology and experimental therapeutics. vol 256. issue 2. 1991-03-21. PMID:1671602. the polyamine agonists spermine and spermidine enhanced [3h]mk-801 binding in all regions studied, with increases ranging from 18% in the thalamus to 106% in the ventromedial striatum. 1991-03-21 2023-08-11 rat
S Subramaniam, P McGonigl. Quantitative autoradiographic characterization of the binding of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine ([3H]MK-801) in rat brain: regional effects of polyamines. The Journal of pharmacology and experimental therapeutics. vol 256. issue 2. 1991-03-21. PMID:1671602. diethylenetriamine, which blocks the effects of spermidine, by itself produced decreases in the binding of [3h]mk-801 in most regions ranging from 5 to 21% but increased binding in parts of the striatum by 3 to 22%. 1991-03-21 2023-08-11 rat
J W McDonald, F S Silverstein, M V Johnsto. MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats. Neuroscience. vol 38. issue 1. 1991-01-24. PMID:2255390. a 2 h mk-801 pretreatment produced a 30-50% increase in [3h]glutamate binding at n-methyl-d-aspartate preferring recognition sites in all four brain regions examined (areas ca1 and ca3 of the hippocampus, corpus striatum, cingulate cortex) in comparison with saline-treated controls (p less than 0.05, anova). 1991-01-24 2023-08-11 rat
M R Rod, I Q Whishaw, R N Aue. The relationship of structural ischemic brain damage to neurobehavioural deficit: the effect of postischemic MK-801. Canadian journal of psychology. vol 44. issue 2. 1990-09-20. PMID:2200595. mk-801 totally prevented neuronal necrosis in both the cerebral cortex and striatum and also prevented infarction in the neocortex and thalamus. 1990-09-20 2023-08-11 rat
W Dimpfel, M Spüle. Dizocilpine (MK-801), ketamine and phencyclidine: low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission. Psychopharmacology. vol 101. issue 3. 1990-08-08. PMID:2163537. mk-801 produced strongly dose-dependent effects which could be followed quantitatively over a time of 4 h. during this time spectral analysis of the field potentials continuously recorded from frontal cortex, hippocampus, striatum, and reticular formation revealed a particular pattern of changes which was very stable over time, and after low doses of 0.05 and 0.1 mg/kg, matched that produced by phencyclidine (2 and 4 mg/kg) or ketamine chloride (10 and 20 mg/kg). 1990-08-08 2023-08-11 rat
A B Norman, L M Ford, M Kolmonpunporn, P R Sanber. Chronic treatment with MK-801 increases the quinolinic acid-induced loss of D-1 dopamine receptors in rat striatum. European journal of pharmacology. vol 176. issue 3. 1990-05-31. PMID:2139415. chronic treatment with mk-801 increases the quinolinic acid-induced loss of d-1 dopamine receptors in rat striatum. 1990-05-31 2023-08-11 rat
A B Norman, L M Ford, M Kolmonpunporn, P R Sanber. Chronic treatment with MK-801 increases the quinolinic acid-induced loss of D-1 dopamine receptors in rat striatum. European journal of pharmacology. vol 176. issue 3. 1990-05-31. PMID:2139415. following withdrawal from short-term treatment with the non-competitive n-methyl-d-aspartate receptor antagonist mk-801 (1 mg/kg per day) there was no significant change in the bmax or kd of [3h]sch23390 binding to dopamine d-1 receptors in rat striatum. 1990-05-31 2023-08-11 rat
T S Rao, H S Kim, J Lehmann, L L Martin, P L Woo. Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat. Journal of neurochemistry. vol 54. issue 4. 1990-04-20. PMID:2156013. mk-801 increased dopamine (da) metabolism in the pyriform cortex, entorhinal cortex, prefrontal cortex, striatum, olfactory tubercle, amygdala, and septum without affecting da metabolism in the cingulate cortex and nucleus accumbens. 1990-04-20 2023-08-11 rat
A C Foster, R Gill, G N Woodruf. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 8. issue 12. 1989-01-26. PMID:2904493. the ability of the noncompetitive n-methyl-d-aspartate (nmda) receptor antagonist mk-801 to prevent neuronal degeneration in the rat striatum and hippocampus caused by intracerebral injection of excitotoxins has been examined. 1989-01-26 2023-08-11 rat
A C Foster, R Gill, G N Woodruf. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 8. issue 12. 1989-01-26. PMID:2904493. in the striatum, significant protection of cholinergic neurons (assessed by chat measurements) was observed when mk-801 was given up to 5 hr after injection of nmda or quinolinate, whereas protection of gabaergic neurons (assessed by gad measurements) was obtained up to 2 hr. 1989-01-26 2023-08-11 rat
G E Marti. Catecholamine release within the striatum of the freely moving rat. Annals of the New York Academy of Sciences. vol 473. 1987-02-19. PMID:3541735. in the second experiment, mk-801, a novel experimental compound, was found to be dissimilar from amphetamine insofar as it does not produce the release of [3h]dopamine from the striatum during its local application. 1987-02-19 2023-08-11 rat